DI, SIADH AND CSWS
Amro al tarawneh
Similarities – What’s in common?
Central neurogenic diabetes insipidus (CNDI), syndrome of
inappropriate secretion of antidiuretic hormone (SIADH), and
cerebral salt-wasting syndrome (CSWS(
ALL affect both sodium and water balance; however, they
have differences in pathophysiology, diagnosis,
and treatment.
Antidiuretic hormone (ADH(
 A polypeptide synthesized
in the supraoptic and
paraventricular nuclei in
the hypothalamus.
 Secretory granules
containing ADH migrate
down into the posterior
lobe of the pituitary,
where they are stored and
released after appropriate
stimuli.
Anatomy of pitutary
 Situated in the pituatry fossa
limited anterior , posterior ,
inferior by bony constituents of
sella turcica “ depression in the
body of sphenoid bone “
 Demarcated laterally , superiorly
by reflection of dura and sella
turcica
Don’t injury me ,,, I will flood your
ICU
Antidiuretic hormone (ADH(
 ADH increase the
permeability of the renal
distal tubule and
collecting ducts to water
 Less free water is
excreted in urine
 Urine volume is
decreased
 Concentration of urine
is increased
Antidiuretic hormone (ADH(
Diabetes Insipidus
A hormone disorder that
occurs when the body
doesn’t produce enough
antidiuretic hormone (ADH)
or doesn't use the hormone
effectively “ urinary system
doesn’t responed >>
excretion of excessive
quantities of very dilute, but
otherwise normal urine.
Diabetes Insipidus – Types
Types:
1. Central DI, a primary deficiency of ADH
2. Nephrogenic DI, caused by an inappropriate renal
response to ADH
3. Gestational DI , only during pregnancy when enzyme
from placenta destroys ADH in the mother
Central DI
 The cause of central diabetes insipidus in adults is
usually damage to the pituitary gland or hypothalamus
 Idiopathic - 30%
 Malignant or benign tumors of the brain or pituitary - 25% “
craniopharyngoma , metastatic carcinoma “
 Cranial surgery - 20% “
 Head trauma - 16% “ skull fracture , hge , concussion “
 Inflammation : meningitis , TB , syphilis
 Vascular : sclerosis , thrombosis of unknown
 Brain infarction , shehan’s syndrome
Post Surgical Central DI
 Postsurgical diabetes insipidus results
from inflammatory edema around the
hypothalamus or posterior pituitary
and resolves with resolution of the
edema. It may also be secondary to
damage to the supraoptic and
paraventricular neurons of the
hypothalamus, the pituitary stalk, or
Pituitary Vasculature
 The neurohypophysis is supplied by
the inferior hypophyseal arteries
terminal branches of the
meningohypophyseal trunk, which
arises from the cavernous portion
of the internal carotid artery
Diabetes Insipidus - Symptoms
Characterized by:
 Excessive thirst that may be intense or uncontrollable, usually
with the need to drink large amounts of water
 Excessive urine volume That is hypotonic, dilute and tasteless
(insipid) , dehydration .
 Excessive urination, often needing to urinate every hour
throughout the day and night ” nocturia “
Central DI - Diagnosis
Complication
 Hypernatremia , hyperosmolarity , dehydration
if sufficient water intake or hypotonic iv fluid
not provide .
 Hypokalemia , hypomagnesmia ,
hypophosphatemia .
Investigation:
 sample of blood & urine, calcium , plasma
elevated , dynamic test .
 Assement of anterior pitutary function &
suprasellar anatomy .
 Mri “ bright spot in the sella “
How to differnate between central &
nephrogenic by plasma AVPlevels afterwater
deprivation orspontaeous development of
mild hypernatremia .
Central DI – Treatments
 Desmopressin is the drug of choice.
 Expectant monitoring by water balance , frequency
meusrement of Na , K , Mg , P then
IV hypotonic solutions (0.45% saline) to replace urine output
to avoid dehydration .
 Tretment of tumor if cause
Syndrome of Inappropriate Antidiuretic Hormone
Secretion (SIADH(
 Hyponatremia and hypo-osmolality resulting from
inappropriate, excess secretion or action of ADH despite
normal or increased plasma volume, which results in
impaired water excretion.
SIADH – Causes
 Any CNS disorder, including stroke,
hemorrhage (very common in SAH population
& subdural hge ), infection, trauma, and
psychosis .
 Ectopic production of ADH by a tumor is
most often due to a small cell carcinoma of
the lung and is rarely seen with other lung
tumors. Less common causes of malignancy-
associated SIADH include head and neck
cancer, olfactory neuroblastoma
(esthesioneuroblastoma), and
extrapulmonary small cell carcinomas.
 Certain drugs can enhance ADH release or
effect, including chlorpropamide,
carbazapine, oxcarbazepine (a derivative of
carbamazepine), high-dose intravenous
cyclophosphamide, and desmopressin .
 Pulmonary diseases, particularly pneumonia
(viral, bacterial, tuberculous) , abscess, can
lead to the SIADH, although the mechanism
by which this occurs is not clear.
SIADH – Pathophysiology
 ADH-induced water retention
 Dilutional hyponatremia
 Volume expansion >> secondary natriuresis (ANP)
 Sodium and water loss
 Result: Euvolemic hyponatremia cause acute cerebral edema
 Reduced serum osmolality
 Increased urine osmolality
 Increased urine sodium
 Brain ECF moves into CSF .
SIADH – Symptoms
 serum sodium >125 meq/ml : anorexia, Nausea , vomiting , malasie .
 Further decrease : headache , Muscle Cramps or tremors
Depressed mood or memory impairment
Irritability , seizures , coma .
 Personality changes : combativeness, confusion and hallucinations .
 Symptoms from CNS or pulmonary tumors : hemptysis , chronic
headaches .
 Sever or rapid onset hyponatrima : delirim , muscle cramps ,
hyperreflexia , dysarrthia , chyne-stoke respiration .
 No edema , dry mucous membrane , decrease skin turgor .
SIADH – Diagnosis
 Euvolemic hyponatremia <134 mEq/L .
 Serum Osm <275 mOsm/kg .
 Urine osmolality >300 mOsm/kg .
 Urine sodium concentration >40 mEq/L with normal dietary
salt intake .
 Radiological image :
1- chest x-ray for pulmonary causes .
2- CT & MRI .
SIADH – Treatment
 Treat the underlying cause, if known ( hormonal replacment in adrenal insuffiency ) .
 Water restriction to about 500-1500 mL/d
 Correct Na+ deficit: no more than 10mEq/L in 24 hours, 18mEq/L in 48 hours
 0.9% NaCl
 3% NaCl
 NaCl enteral tablets – 2-3g TID
 Vasopressin receptor antagonists: inhibition of the AVP V2 receptor reduces the number of
aquaporin-2 water channels in the renal collecting duct and decreases the water
permeability of the collecting duct; There are 2 aquaretics that are currently FDA approved:
• Conivaptan (Vaprisol)
• Tolvaptan
 loop diuretic: usually used in conjunction with normal saline to replenish the Na+ excreted
with the diuresis
 Demeclocycline.
 Prolonged therapy in pt with persistent SIADH .
Cerebral Salt Wasting Syndrome (CSWS(
 Cerebral salt-wasting syndrome (CSWS) is a rare endocrine
condition featuring a low blood sodium concentration
‘ hyponatremia ‘ and dehydration ‘ hypovolemic ‘ in
response to trauma/injury or the presence of tumors in or
surrounding the brain.
 Hypernatremia is common electrolyte disorder in the
setting of cns disease & CSWS potential cause of
hyponatremia .
CSWS – Causes
Condition leading to CSW include the following:
 Head injury
 Hydrocephalous
 Brain tumor
 Intracranial surgery
 Stroke
 Intracerebral hemorrhage
 Tuberculous meningitis
CSWS – Pathophysiology
 Sympathetic Nervous System
Hypothesis: loss of adrenergic tone
to nephron >> decrease in renin
secretion by juxtaglomerular cells,
thereby causing decreased levels of
aldosterone and decreased sodium
reabsorption at PCT.
 Natriuretic Peptide Theory: a
release of natriuretic factors,
possibly including brain natriuretic
peptide (C-type natriuretic peptide)
by the injured brain , which
decreases sodium reabsorption and
inhibits renin.
CSWS – Symptoms
 As the decline in serum sodium concentration reduces
serum osmolality, a tonicity gradient develops across the
blood-brain barrier that causes cerebral edema.
 Symptoms include lethargy, agitation, headache, altered consciousness, seizures,
and coma.
 Intravascular volume depletion
 thirst, abrupt weight loss, decreasing urinary frequency, and negative fluid balance.
Signs::
 Signs of hyponatremia : altered mental status ,
seuziers , coma .
 Signs of volume depltion :
orthostatic hypotension , Increase capillary refil time ,
Dry mucos membrane , skin turgor , sunken anterior
fontanel
CSWS – Diagnosis
 Hyponatremia < 135 meq/L with a low plasma osmolality
 An inappropriately elevated urine osmolality >
100 mosmol/kg and > 300 mosmol/kg)
 A urine sodium concentration > 40 meq/L
 A low serum uric acid concentration due to urate wasting in
the urine
CSWS – Treatment
 IV hypertonic saline solutions are employed to correct
intravascular volume depletion and hyponatremia and to
replace ongoing urinary sodium loss.
 Mineralocorticoids enhance sodium reabsorption in the
kidney by direct action on distal tubule cells
 Fludrocortisone 
Summary
CentralCentral DIDI is associated withis associated with HYPERnatremia,HYPERnatremia,
SIADHSIADH andand CSWSCSWS are associated withare associated with HYPOnatremia.HYPOnatremia.
Summary – SIADH vs. CSWS
Summary – SIADH vs. CSWS vs. DI
SIADH CSWS DI
Serum Na+
Urine Na+
Serum Osm
Urine Osm
Summary – SIADH vs. CSWS vs. DI
SIADH CSWS DI
Urine O/P oliguria polyuria polyuria
CVP normal/high low normal/low
Plasma ADH high normal low
Rx Fluid restrict, give
Na+, Conivaptan,
Demeclocycline
Give volume, give
Na+,
Fludrocortisone
Drink to thirst,
45% saline,
DDAVP
(central), HCTZ
(nephrogenic)
Di, siadh and csws

Di, siadh and csws

  • 1.
    DI, SIADH ANDCSWS Amro al tarawneh
  • 2.
    Similarities – What’sin common? Central neurogenic diabetes insipidus (CNDI), syndrome of inappropriate secretion of antidiuretic hormone (SIADH), and cerebral salt-wasting syndrome (CSWS( ALL affect both sodium and water balance; however, they have differences in pathophysiology, diagnosis, and treatment.
  • 3.
    Antidiuretic hormone (ADH( A polypeptide synthesized in the supraoptic and paraventricular nuclei in the hypothalamus.  Secretory granules containing ADH migrate down into the posterior lobe of the pituitary, where they are stored and released after appropriate stimuli.
  • 4.
    Anatomy of pitutary Situated in the pituatry fossa limited anterior , posterior , inferior by bony constituents of sella turcica “ depression in the body of sphenoid bone “  Demarcated laterally , superiorly by reflection of dura and sella turcica Don’t injury me ,,, I will flood your ICU
  • 5.
    Antidiuretic hormone (ADH( ADH increase the permeability of the renal distal tubule and collecting ducts to water  Less free water is excreted in urine  Urine volume is decreased  Concentration of urine is increased
  • 6.
  • 7.
    Diabetes Insipidus A hormonedisorder that occurs when the body doesn’t produce enough antidiuretic hormone (ADH) or doesn't use the hormone effectively “ urinary system doesn’t responed >> excretion of excessive quantities of very dilute, but otherwise normal urine.
  • 8.
    Diabetes Insipidus –Types Types: 1. Central DI, a primary deficiency of ADH 2. Nephrogenic DI, caused by an inappropriate renal response to ADH 3. Gestational DI , only during pregnancy when enzyme from placenta destroys ADH in the mother
  • 9.
    Central DI  Thecause of central diabetes insipidus in adults is usually damage to the pituitary gland or hypothalamus  Idiopathic - 30%  Malignant or benign tumors of the brain or pituitary - 25% “ craniopharyngoma , metastatic carcinoma “  Cranial surgery - 20% “  Head trauma - 16% “ skull fracture , hge , concussion “  Inflammation : meningitis , TB , syphilis  Vascular : sclerosis , thrombosis of unknown  Brain infarction , shehan’s syndrome
  • 10.
    Post Surgical CentralDI  Postsurgical diabetes insipidus results from inflammatory edema around the hypothalamus or posterior pituitary and resolves with resolution of the edema. It may also be secondary to damage to the supraoptic and paraventricular neurons of the hypothalamus, the pituitary stalk, or Pituitary Vasculature  The neurohypophysis is supplied by the inferior hypophyseal arteries terminal branches of the meningohypophyseal trunk, which arises from the cavernous portion of the internal carotid artery
  • 11.
    Diabetes Insipidus -Symptoms Characterized by:  Excessive thirst that may be intense or uncontrollable, usually with the need to drink large amounts of water  Excessive urine volume That is hypotonic, dilute and tasteless (insipid) , dehydration .  Excessive urination, often needing to urinate every hour throughout the day and night ” nocturia “
  • 12.
    Central DI -Diagnosis
  • 13.
    Complication  Hypernatremia ,hyperosmolarity , dehydration if sufficient water intake or hypotonic iv fluid not provide .  Hypokalemia , hypomagnesmia , hypophosphatemia .
  • 14.
    Investigation:  sample ofblood & urine, calcium , plasma elevated , dynamic test .  Assement of anterior pitutary function & suprasellar anatomy .  Mri “ bright spot in the sella “ How to differnate between central & nephrogenic by plasma AVPlevels afterwater deprivation orspontaeous development of mild hypernatremia .
  • 15.
    Central DI –Treatments  Desmopressin is the drug of choice.  Expectant monitoring by water balance , frequency meusrement of Na , K , Mg , P then IV hypotonic solutions (0.45% saline) to replace urine output to avoid dehydration .  Tretment of tumor if cause
  • 16.
    Syndrome of InappropriateAntidiuretic Hormone Secretion (SIADH(  Hyponatremia and hypo-osmolality resulting from inappropriate, excess secretion or action of ADH despite normal or increased plasma volume, which results in impaired water excretion.
  • 17.
    SIADH – Causes Any CNS disorder, including stroke, hemorrhage (very common in SAH population & subdural hge ), infection, trauma, and psychosis .  Ectopic production of ADH by a tumor is most often due to a small cell carcinoma of the lung and is rarely seen with other lung tumors. Less common causes of malignancy- associated SIADH include head and neck cancer, olfactory neuroblastoma (esthesioneuroblastoma), and extrapulmonary small cell carcinomas.  Certain drugs can enhance ADH release or effect, including chlorpropamide, carbazapine, oxcarbazepine (a derivative of carbamazepine), high-dose intravenous cyclophosphamide, and desmopressin .  Pulmonary diseases, particularly pneumonia (viral, bacterial, tuberculous) , abscess, can lead to the SIADH, although the mechanism by which this occurs is not clear.
  • 18.
    SIADH – Pathophysiology ADH-induced water retention  Dilutional hyponatremia  Volume expansion >> secondary natriuresis (ANP)  Sodium and water loss  Result: Euvolemic hyponatremia cause acute cerebral edema  Reduced serum osmolality  Increased urine osmolality  Increased urine sodium  Brain ECF moves into CSF .
  • 19.
    SIADH – Symptoms serum sodium >125 meq/ml : anorexia, Nausea , vomiting , malasie .  Further decrease : headache , Muscle Cramps or tremors Depressed mood or memory impairment Irritability , seizures , coma .  Personality changes : combativeness, confusion and hallucinations .  Symptoms from CNS or pulmonary tumors : hemptysis , chronic headaches .  Sever or rapid onset hyponatrima : delirim , muscle cramps , hyperreflexia , dysarrthia , chyne-stoke respiration .  No edema , dry mucous membrane , decrease skin turgor .
  • 20.
    SIADH – Diagnosis Euvolemic hyponatremia <134 mEq/L .  Serum Osm <275 mOsm/kg .  Urine osmolality >300 mOsm/kg .  Urine sodium concentration >40 mEq/L with normal dietary salt intake .  Radiological image : 1- chest x-ray for pulmonary causes . 2- CT & MRI .
  • 21.
    SIADH – Treatment Treat the underlying cause, if known ( hormonal replacment in adrenal insuffiency ) .  Water restriction to about 500-1500 mL/d  Correct Na+ deficit: no more than 10mEq/L in 24 hours, 18mEq/L in 48 hours  0.9% NaCl  3% NaCl  NaCl enteral tablets – 2-3g TID  Vasopressin receptor antagonists: inhibition of the AVP V2 receptor reduces the number of aquaporin-2 water channels in the renal collecting duct and decreases the water permeability of the collecting duct; There are 2 aquaretics that are currently FDA approved: • Conivaptan (Vaprisol) • Tolvaptan  loop diuretic: usually used in conjunction with normal saline to replenish the Na+ excreted with the diuresis  Demeclocycline.  Prolonged therapy in pt with persistent SIADH .
  • 22.
    Cerebral Salt WastingSyndrome (CSWS(  Cerebral salt-wasting syndrome (CSWS) is a rare endocrine condition featuring a low blood sodium concentration ‘ hyponatremia ‘ and dehydration ‘ hypovolemic ‘ in response to trauma/injury or the presence of tumors in or surrounding the brain.  Hypernatremia is common electrolyte disorder in the setting of cns disease & CSWS potential cause of hyponatremia .
  • 23.
    CSWS – Causes Conditionleading to CSW include the following:  Head injury  Hydrocephalous  Brain tumor  Intracranial surgery  Stroke  Intracerebral hemorrhage  Tuberculous meningitis
  • 24.
    CSWS – Pathophysiology Sympathetic Nervous System Hypothesis: loss of adrenergic tone to nephron >> decrease in renin secretion by juxtaglomerular cells, thereby causing decreased levels of aldosterone and decreased sodium reabsorption at PCT.  Natriuretic Peptide Theory: a release of natriuretic factors, possibly including brain natriuretic peptide (C-type natriuretic peptide) by the injured brain , which decreases sodium reabsorption and inhibits renin.
  • 25.
    CSWS – Symptoms As the decline in serum sodium concentration reduces serum osmolality, a tonicity gradient develops across the blood-brain barrier that causes cerebral edema.  Symptoms include lethargy, agitation, headache, altered consciousness, seizures, and coma.  Intravascular volume depletion  thirst, abrupt weight loss, decreasing urinary frequency, and negative fluid balance.
  • 26.
    Signs::  Signs ofhyponatremia : altered mental status , seuziers , coma .  Signs of volume depltion : orthostatic hypotension , Increase capillary refil time , Dry mucos membrane , skin turgor , sunken anterior fontanel
  • 27.
    CSWS – Diagnosis Hyponatremia < 135 meq/L with a low plasma osmolality  An inappropriately elevated urine osmolality > 100 mosmol/kg and > 300 mosmol/kg)  A urine sodium concentration > 40 meq/L  A low serum uric acid concentration due to urate wasting in the urine
  • 28.
    CSWS – Treatment IV hypertonic saline solutions are employed to correct intravascular volume depletion and hyponatremia and to replace ongoing urinary sodium loss.  Mineralocorticoids enhance sodium reabsorption in the kidney by direct action on distal tubule cells  Fludrocortisone 
  • 29.
    Summary CentralCentral DIDI isassociated withis associated with HYPERnatremia,HYPERnatremia, SIADHSIADH andand CSWSCSWS are associated withare associated with HYPOnatremia.HYPOnatremia.
  • 30.
  • 31.
    Summary – SIADHvs. CSWS vs. DI SIADH CSWS DI Serum Na+ Urine Na+ Serum Osm Urine Osm
  • 32.
    Summary – SIADHvs. CSWS vs. DI SIADH CSWS DI Urine O/P oliguria polyuria polyuria CVP normal/high low normal/low Plasma ADH high normal low Rx Fluid restrict, give Na+, Conivaptan, Demeclocycline Give volume, give Na+, Fludrocortisone Drink to thirst, 45% saline, DDAVP (central), HCTZ (nephrogenic)